The NeuroCircuit logo
The NeuroCircuit
Reading List
Subscribe
  • The NeuroCircuit
  • Topics
  • Industry & Leadership Updates

Industry & Leadership Updates

Shifts in leadership, regulatory approvals, funding rounds, and commercialization strategies across the neurotech sector.

Brain-to-VoiceClosed-loop DBSNeurotechnologyNeurohackingEthics & PolicyNeurorehabilitation & RoboticsNeuroscienceNeuralink Gene & Cell Therapies in NeurotechClinical Trial NewsIndustry & Leadership UpdatesBrain-Computer Interfaces (BCI)Sensory VR & BCIsNeural EngineeringEmerging TechNeurotech NewsNeural ImplantsInnovationDIY Neuro
Ethics & PolicyEthics & Policy
+5+5
Weekly Signal: 33 | Mind Captioning, Neural Barcodes, and Neurotech Ethics
Nov 15, 2025

Weekly Signal: 33 | Mind Captioning, Neural Barcodes, and Neurotech Ethics

Decoding, biomarkers, and governance

Ricardo Albornoz
NeurotechnologyNeurotechnology
+6+6
Weekly Signal: 32 | Tiny Implants, Big Governance
Nov 08, 2025

Weekly Signal: 32 | Tiny Implants, Big Governance

Miniaturized BCIs & Global Neuro-Ethics

Ricardo Albornoz
NeurotechnologyNeurotechnology
+6+6
Weekly Signal: 31 | FcRn Trials, Neuromodulation Breakthroughs, and Neuro-Rights
Nov 01, 2025

Weekly Signal: 31 | FcRn Trials, Neuromodulation Breakthroughs, and Neuro-Rights

Clinical data, funding moves, and policy shifts

Ricardo Albornoz
NeurotechnologyNeurotechnology
+4+4
Weekly Signal: 30 | Vision Restored, Minds Regulated: Neurotech’s Pivotal Week
Oct 25, 2025

Weekly Signal: 30 | Vision Restored, Minds Regulated: Neurotech’s Pivotal Week

Clinical Breakthroughs & Global Policy Shifts

Ricardo Albornoz
Closed-loop DBSClosed-loop DBS
+6+6
Weekly Signal: 29 | Synapses, Stimulators & Safeguards
Oct 18, 2025

Weekly Signal: 29 | Synapses, Stimulators & Safeguards

Mechanisms, markets, and mental privacy

Ricardo Albornoz
NeurotechnologyNeurotechnology
+6+6
Weekly Signal: 28 | Neural Interfaces Meet Empathy and Expansion
Oct 11, 2025

Weekly Signal: 28 | Neural Interfaces Meet Empathy and Expansion

From Parkinson’s progress to pain-sharing tech

Ricardo Albornoz
Closed-loop DBSClosed-loop DBS
+6+6
Weekly Signal: 27 | BCI Gains, DBS Updates & Policy
Oct 04, 2025

Weekly Signal: 27 | BCI Gains, DBS Updates & Policy

Clinical signals, market moves

Ricardo Albornoz
NeurotechnologyNeurotechnology
+6+6
Weekly Signal: 26 |Gene Therapy, HD-EEG, and Neural Rights
Sep 27, 2025

Weekly Signal: 26 |Gene Therapy, HD-EEG, and Neural Rights

Clinical, industry, and policy signals

Ricardo Albornoz
NeurotechnologyNeurotechnology
+6+6
Weekly Signal: 24 | Therapies, Tracers & Tech Shifts
Sep 13, 2025

Weekly Signal: 24 | Therapies, Tracers & Tech Shifts

Clinical wins & data rules

Ricardo Albornoz
Ethics & PolicyEthics & Policy
+5+5
Weekly Signal: 23 | Neurotech on the Edge: BCI Breakthroughs
Sep 07, 2025

Weekly Signal: 23 | Neurotech on the Edge: BCI Breakthroughs

Privacy, Therapy & Beyond

Ricardo Albornoz
Ethics & PolicyEthics & Policy
+3+3
Weekly Signal: 21 | Noninvasive Neuromodulation Steps Forward
Aug 23, 2025

Weekly Signal: 21 | Noninvasive Neuromodulation Steps Forward

Graphene control, FDA wins

Ricardo Albornoz
NeurotechnologyNeurotechnology
+3+3
Weekly Signal 20 | Inner-Speech BCI, ENCELTO milestone 🧠
Aug 17, 2025

Weekly Signal 20 | Inner-Speech BCI, ENCELTO milestone 🧠

BCI, industry moves, and neural privacy—this week’s signals.

Ricardo Albornoz
The NeuroCircuit delivers cutting-edge neurotechnology news, insights, and tools straight to the minds shaping the future.

The NeuroCircuit

The NeuroCircuit delivers cutting-edge neurotechnology news, insights, and tools straight to the minds shaping the future.

Home

Posts

NeuroCircuit Reading List

Reading List

© 2025 The NeuroCircuit.

Privacy policy

Terms of use

Powered by beehiiv